Author

R. Li

Observed institution: Fudan University Shanghai Cancer Center

OpenAlex ID: A5111328233

2242P Clinical observation of nimotuzumab combined with AG regimen sequential irreversible electroporation (IRE) ablation in the treatment of locally advanced pancreatic cancer

2025 · C. Gao, J. Hao, et al. · Annals of Oncology

980P Hepatic artery infusion chemotherapy (HAIC) plus sintilimab and bevacizumab biosimilar (IBI305) for initial unresectable hepatocellular carcinoma (HCC) in patients with Child-Pugh B liver function: A prospective study

2024 · H. Li, X. Zhang, et al. · Annals of Oncology

The Treatment Choice Based on Radiographic Features for Metastatic Brain Tumors in ALK-Rearranged Non–small Cell Lung Cancer

2017 · L. CHU, R. Li, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 3

Citation count:

H-index:

I10-index: